Pain News and Research

Latest Pain News and Research

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

Montefiore, Burke partner to increase availability of rehabilitation therapies in Westchester County and beyond

Montefiore, Burke partner to increase availability of rehabilitation therapies in Westchester County and beyond

Mylan releases generic version of Zosyn Injection in the U.S.

Mylan releases generic version of Zosyn Injection in the U.S.

Shire enters into agreement with Sanquin for CINRYZE

Shire enters into agreement with Sanquin for CINRYZE

Medical case report of woman with Channelopathy-associated Insensitivity to Pain Syndrome

Medical case report of woman with Channelopathy-associated Insensitivity to Pain Syndrome

AMA Task Force to Reduce Opioid Abuse announces national recommendations to address opioid crisis

AMA Task Force to Reduce Opioid Abuse announces national recommendations to address opioid crisis

Researchers evaluate use of pharmacy-based naloxone education and distribution to fight opioid overdoses

Researchers evaluate use of pharmacy-based naloxone education and distribution to fight opioid overdoses

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

SI-BONE announces publication of results from INSITE and SIFI studies

SI-BONE announces publication of results from INSITE and SIFI studies

Three medical oncologists to receive ESMO's acclaimed awards

Three medical oncologists to receive ESMO's acclaimed awards

Mexican engineer designs new ring that can help diagnose sexually transmitted diseases

Mexican engineer designs new ring that can help diagnose sexually transmitted diseases

Study finds significant decline in CT usage at children's hospitals for common childhood diagnoses

Study finds significant decline in CT usage at children's hospitals for common childhood diagnoses

Novel technique may lead to therapies for pain relief in individuals with intractable pain

Novel technique may lead to therapies for pain relief in individuals with intractable pain

Psychiatric disorders may follow trigeminal neuralgia

Psychiatric disorders may follow trigeminal neuralgia

Loyola University Medical Center first in Illinois to offer new, noninvasive test for heart disease

Loyola University Medical Center first in Illinois to offer new, noninvasive test for heart disease

Medicaid could save billions as patents for several blockbuster antipsychotic medications expire

Medicaid could save billions as patents for several blockbuster antipsychotic medications expire

FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity

FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity

Nuvo Research granted U.S. patent for novel topical foam formulations that use DMSO to enhance drug delivery

Nuvo Research granted U.S. patent for novel topical foam formulations that use DMSO to enhance drug delivery

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

New scientific conference 'Aspirin in the 21st Century' to be held in London

New scientific conference 'Aspirin in the 21st Century' to be held in London

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.